Skip to main content
Back

EVS-EN ISO 14155:2020/A11:2025

Clinical investigation of medical devices for human subjects - Good clinical practice

General information

Valid from 17.03.2025
Base Documents
EN ISO 14155:2020/A11:2024
Directives or regulations
2017/745 Medical devices (MDR)

Standard history

Status
Date
Type
Name
17.03.2025
Amendment
17.03.2025
Main + amendment
02.10.2020
Main
This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in
human subjects to assess the clinical performance or effectiveness and safety of medical devices.
For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant,
considering the nature of the clinical investigation (see AnnexI).
This document specifies general requirements intended to
- protect the rights, safety and well-being of human subjects,
- ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results,
- define the responsibilities of the sponsor and principal investigator, and
- assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of
medical devices.
NOTE1 Users of this document need to consider whether other standards and/or national requirements also apply to the
investigational device(s) under consideration or the clinical investigation. If differences in requirements exist, the most stringent apply.
NOTE2 For Software as a Medical Device (SaMD) demonstration of the analytical validity (the SaMD’s output is accurate for a given
input), and where appropriate, the scientific validity (the SaMD’s output is associated to the intended clinical condition/physiological
state), and clinical performance (the SaMD’s output yields a clinically meaningful association to the target use) of the SaMD, the
requirements of this document apply as far as relevant (see Reference[4]). Justifications for exemptions from this document can
consider the uniqueness of indirect contact between subjects and the SaMD.
This document does not apply to in vitro diagnostic medical devices. However, there can be situations, dependent on the device and
national or regional requirements, whereusers of this document might consider whether specific sections and/or requirements of this
document could be applicable.

Required fields are indicated with *

*
*
*
PDF
16.12 € incl tax
Paper
16.12 € incl tax
Browse standard from 2.48 € incl tax
Standard monitoring

Customers who bought this item also bought

Main + amendment

EVS-EN ISO 10993-5:2009+A11:2025

Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
Newest version Valid from 02.06.2025
Amendment

EVS-EN ISO 10993-5:2009/A11:2025

Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
Valid from 15.05.2025
Main

EVS-EN 868-2:2025

Packaging for terminally sterilized medical devices - Part 2: Sterilization wrap - Requirements and test methods
Newest version Valid from 15.05.2025
Amendment

EVS-EN ISO 10993-4 V2:2017/A1:2025

Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04)
Valid from 17.03.2025